Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Dr Elizabeth Ormondroyd comments on recent NHS plans in The Conversation.

Nhs plan to sell genome sequencing to healthy people is premature

Dr Ormondroyd, a genetic counsellor and an RDM researcher, explores the implications of new NHS proposals to offer healthy people a paid service to have their genome sequence, and points out the difficulties in interpreting genome sequencing data for healthy people with no family history of a particular disease. 

Read the full article at The Conversation